Logo image of XPER

XPERI INC (XPER) Stock Fundamental Analysis

NYSE:XPER - US98423J1016 - Common Stock

6.04 USD
-0.05 (-0.82%)
Last: 8/28/2025, 7:47:31 PM
6.04 USD
0 (0%)
After Hours: 8/28/2025, 7:47:31 PM
Fundamental Rating

3

Overall XPER gets a fundamental rating of 3 out of 10. We evaluated XPER against 282 industry peers in the Software industry. The financial health of XPER is average, but there are quite some concerns on its profitability. XPER has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year XPER was profitable.
XPER had a negative operating cash flow in the past year.
In the past 5 years XPER always reported negative net income.
XPER had negative operating cash flow in 4 of the past 5 years.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of XPER (-0.59%) is comparable to the rest of the industry.
XPER has a Return On Equity of -0.89%. This is in the better half of the industry: XPER outperforms 61.35% of its industry peers.
Industry RankSector Rank
ROA -0.59%
ROE -0.89%
ROIC N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 75.13%, XPER is in the better half of the industry, outperforming 67.73% of the companies in the same industry.
XPER's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XPER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPER has been increased compared to 1 year ago.
Compared to 5 years ago, XPER has less shares outstanding
The debt/assets ratio for XPER is higher compared to a year ago.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.36, we must say that XPER is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XPER (-0.36) is worse than 72.69% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that XPER is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.10, XPER perfoms like the industry average, outperforming 54.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACC11.09%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.50 indicates that XPER has no problem at all paying its short term obligations.
XPER's Current ratio of 2.50 is fine compared to the rest of the industry. XPER outperforms 70.21% of its industry peers.
A Quick Ratio of 2.50 indicates that XPER has no problem at all paying its short term obligations.
The Quick ratio of XPER (2.50) is better than 70.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1070.00% over the past year.
The earnings per share for XPER have been decreasing by -21.24% on average. This is quite bad
XPER shows a decrease in Revenue. In the last year, the revenue decreased by -6.10%.
The Revenue has been growing by 20.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1070%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%-8.33%
Revenue 1Y (TTM)-6.1%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-11.42%

3.2 Future

The Earnings Per Share is expected to grow by 6.32% on average over the next years.
The Revenue is expected to decrease by -2.28% on average over the next years.
EPS Next Y-11.92%
EPS Next 2Y6.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.35%
Revenue Next 2Y-2.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.16, the valuation of XPER can be described as very cheap.
95.39% of the companies in the same industry are more expensive than XPER, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.17. XPER is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.51, which indicates a rather cheap valuation of XPER.
Based on the Price/Forward Earnings ratio, XPER is valued cheaply inside the industry as 97.16% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.78, XPER is valued rather cheaply.
Industry RankSector Rank
PE 5.16
Fwd PE 5.51
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XPER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPERI INC

NYSE:XPER (8/28/2025, 7:47:31 PM)

After market: 6.04 0 (0%)

6.04

-0.05 (-0.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners90.13%
Inst Owner Change3.6%
Ins Owners3.11%
Ins Owner Change14.2%
Market Cap279.41M
Analysts82
Price Target11.22 (85.76%)
Short Float %4.55%
Short Ratio5.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)313.46%
Min EPS beat(2)13.91%
Max EPS beat(2)613.01%
EPS beat(4)4
Avg EPS beat(4)217.88%
Min EPS beat(4)13.91%
Max EPS beat(4)613.01%
EPS beat(8)7
Avg EPS beat(8)128.79%
EPS beat(12)11
Avg EPS beat(12)110.39%
EPS beat(16)14
Avg EPS beat(16)89.62%
Revenue beat(2)0
Avg Revenue beat(2)-4.82%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)-1.28%
Revenue beat(4)0
Avg Revenue beat(4)-3.29%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)-0.34%
Revenue beat(8)0
Avg Revenue beat(8)-3.99%
Revenue beat(12)1
Avg Revenue beat(12)-3.37%
Revenue beat(16)1
Avg Revenue beat(16)-14.33%
PT rev (1m)-39.73%
PT rev (3m)-39.73%
EPS NQ rev (1m)-7.03%
EPS NQ rev (3m)-39.02%
EPS NY rev (1m)-15.04%
EPS NY rev (3m)-15.04%
Revenue NQ rev (1m)-5.87%
Revenue NQ rev (3m)-14.53%
Revenue NY rev (1m)-5.67%
Revenue NY rev (3m)-5.67%
Valuation
Industry RankSector Rank
PE 5.16
Fwd PE 5.51
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 1.02
EV/EBITDA N/A
EPS(TTM)1.17
EY19.37%
EPS(NY)1.1
Fwd EY18.15%
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS10.27
BVpS9.08
TBVpS5.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.59%
ROE -0.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.13%
FCFM N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.89%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z -0.36
F-Score4
WACC11.09%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1070%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%-8.33%
EPS Next Y-11.92%
EPS Next 2Y6.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.1%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-11.42%
Revenue Next Year-7.35%
Revenue Next 2Y-2.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year743.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.37%
OCF growth 3YN/A
OCF growth 5YN/A